Connor, Clark & Lunn Investment Management Ltd.

Position in PEN — Penumbra Inc

CIK 1596800 VANCOUVER, A1

Position in PEN

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,613,798

+$370,261 QoQ

Shares Held

5,111

+35.0% QoQ

Ownership

0.013%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#208

of 446 holders

Holding Since

Dec 2020

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $204,731,115 across 26 Medical Devices names. PEN ranks #10 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	869,131	$78,864,946
2	BSX	Boston Scientific Corp	1,467,148	$62,617,875
3	PHG	Koninklijke Philips NV	563,724	$15,327,654
4	SNN	Smith & Nephew PLC	487,774	$14,052,767
5	NVCR	NovoCure Ltd	661,280	$10,018,391
6	IRTC	iRhythm Holdings, Inc.	42,314	$5,033,250
7	AXGN	Axogen, Inc.	67,118	$3,100,180
8	VREX	Varex Imaging Corp	293,435	$3,060,526

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,613,798	5,111	+35.0%	Shares	Sole	2026-08-13
2026-03-31	$1,243,537	3,787	-55.8%	Shares	Sole	2026-05-11
2023-12-31	$2,156,200	8,572	+25.6%	Shares	Sole	2024-02-09
2023-09-30	$1,650,793	6,824	-61.0%	Shares	Sole	2023-11-13
2023-06-30	$6,021,394	17,501	+971.1%	Shares	Sole	2023-08-10
2022-03-31	$362,960	1,634	-86.5%	Shares	Sole	2022-05-12
2021-06-30	$3,320,510	12,116	-33.4%	Shares	Sole	2021-08-12
2021-03-31	$4,919,414	18,181	+21.3%	Shares	Sole	2021-05-13
2020-12-31	$2,622,550	14,986	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.